Gene conversions are a common cause of von Willebrand disease

被引:43
作者
Gupta, PK [1 ]
Adamtziki, E
Budde, U
Jaiprakash, M
Kumar, H
Harbeck-Seu, A
Kannan, M
Oyen, F
Obser, T
Wedekind, I
Saxena, R
Schneppenheim, R
机构
[1] Armed Forces Med Coll, Dept Transfus Med BTD, Pune 411040, Maharashtra, India
[2] Aghia Sophia Childrens Hosp, Haemophilia Haemostasis Unit S Aronis Vournas, Athens, Greece
[3] Lademannbogen, Coagulat Lab, Hamburg, Germany
[4] Univ Hamburt Eppendorf, Med Ctr, Dept Paediat Haematol & Oncol, Hamburg, Germany
[5] All India Inst Med Sci, Dept Haematol, New Delhi, India
关键词
gene conversion; type 3 von Willebrand disease; type 2M Vicenza; type 213 New York/Malmoe;
D O I
10.1111/j.1365-2141.2005.05660.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
von Willebrand disease (VWD), the most common inherited bleeding disorder, is very heterogeneous, both in its phenotype and genotype. One particular molecular mechanism of VWD is due to recombination events between the true gene and its pseudogene on chromosome 22. We assessed the frequency and extension of such events in 50 multi-ethnic index patients with severe VWD type 3 and in five index patients with VWD type 2M Vicenza. One additional unclassified patient had been diagnosed with possible VWD in Russia solely on a clinical basis. Gene conversions, previously thought to be rare events, were identified in >10% of our study population: in six multi-ethnic patients with severe VWD type 3, in one patient with VWD type 2M Vicenza and the Russian patient was finally diagnosed with VWD type 213 New York/Malmoe. Our results suggest a significant contribution of this particular molecular mechanism to the manifestation of VWD. The location of the gene conversions, their extension and their occurrence as homozygous, compound heterozygous or heterozygous mutations determines the resulting phenotype.
引用
收藏
页码:752 / 758
页数:7
相关论文
共 25 条
  • [1] Allen S, 2000, BLOOD, V96, P560
  • [2] Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients
    Baronciani, L
    Cozzi, G
    Canciani, MT
    Peyvandi, F
    Srivastava, A
    Federici, AB
    Mannucci, PM
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2003, 30 (03) : 264 - 270
  • [3] AN ELISA TEST FOR THE BINDING OF VONWILLEBRAND ANTIGEN TO COLLAGEN
    BROWN, JE
    BOSAK, JO
    [J]. THROMBOSIS RESEARCH, 1986, 43 (03) : 303 - 311
  • [4] Q1311X:: a novel nonsense mutation of putative ancient origin in the von Willebrand factor gene
    Casaña, P
    Martínez, F
    Haya, S
    Lorenzo, JI
    Espinós, C
    Aznar, JA
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (02) : 552 - 555
  • [5] MULTIPLE SUBSTITUTIONS IN THE VON-WILLEBRAND-FACTOR GENE THAT MIMIC THE PSEUDOGENE SEQUENCE
    EIKENBOOM, JCJ
    VINK, T
    BRIET, E
    SIXMA, JJ
    REITSMA, PH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) : 2221 - 2224
  • [6] Eikenboom JCJ, 1998, THROMB HAEMOSTASIS, V79, P709
  • [7] HARDISTY RM, 1962, THROMB DIATH HAEMOST, V7, P215
  • [8] VONWILLEBRAND-FACTOR MUTATION ENHANCING INTERACTION WITH PLATELETS IN PATIENTS WITH NORMAL MULTIMERIC STRUCTURE
    HOLMBERG, L
    DENT, JA
    SCHNEPPENHEIM, R
    BUDDE, U
    WARE, J
    RUGGERI, ZM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (05) : 2169 - 2177
  • [9] Kanaji T, 1996, INT J HEMATOL, V64, P53
  • [10] CHI, A PROMOTER OF GENERALIZED RECOMBINATION IN LAMBDA-PHAGE, IS PRESENT IN IMMUNOGLOBULIN GENES
    KENTER, AL
    BIRSHTEIN, BK
    [J]. NATURE, 1981, 293 (5831) : 402 - 404